What are the Advantages of Using Liposomal Doxorubicin?
The encapsulation of doxorubicin in liposomes offers several advantages:
Reduced Toxicity: Traditional doxorubicin is associated with severe side effects, including cardiotoxicity. Liposomal encapsulation reduces exposure to healthy tissues and minimizes adverse effects. Improved Efficacy: Enhanced accumulation in tumor tissues increases the therapeutic efficacy of doxorubicin. Extended Circulation Time: Liposomes have a longer half-life in the bloodstream, allowing for sustained drug release and improved therapeutic outcomes.
